Lumenis Introduces New Laser Hair Removal Solution, SPLENDOR X, at the 2018 American Society of Dermatological Surgery (ASDS)

Lumenis Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, excitedly announces its newest launch, SPLENDOR X— the first solid state laser system equipped with the unique BLEND X technology for fast and effective hair removal and skin solutions. The technology will be showcased for the first time at the 2018 American Society of Dermatological Surgery – ASDS in Phoenix from October 11th-October 14th, 2018.

OD Brings In Technology To Help Patients Get Off The Hamster Wheel Of Dry Eye Treatments

Press PublicationsDry Eye OD Brings In Technology To Help Patients Get Off The Hamster Wheel Of Dry Eye Treatments May 15, 2024 Melanie Denton Dombrowski, OD, MBA, FAAO Melanie Denton

Photorejuvenation

Photorejuvenation refers to the use of Intense Pulsed Light (IPL) to treat conditions related to sun-induced skin damage. IPL uses a broad spectrum of light which is primarily absorbed by melanin and oxyhemoglobin and is effective in reducing the appearance of sun spots, capillaries, elastosis and fine lines.

Redefining Dry Eye Care: A Boutique Practice Case Study

Blog PostsDry Eye Redefining Dry Eye Care: A Boutique Practice Case Study January 5, 2026 Tami Le, OD Le Eye Spa, Las Vegas, Nevada

Rosacea

Rosacea is a chronic skin condition which expresses itself in redness on the face and sometimes on the neck and chest. The exact cause of Rosacea is yet unknown and many who are affected by it are unaware of their condition. Rosacea can be effectively treated using Intense Pulsed Light (IPL). IPL uses controlled light in specific wavelengths to alleviate the inflammation, redness, pimples and uneven skin tones caused by the condition. IPL offers a gentle, long-lasting solution for those suffering from Rosacea by providing a gradual and natural improvement to the skin’s appearance.

Toyos et al. (2022) Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: A randomized controlled study

The US FDA approval for Lumenis IPL with OPT™ for management of DED was based on this recent clinical study. In this perspective, multi-center, double-blinded, randomized controlled study, Lumenis IPL with OPT™ combined with MGX significantly improved signs of DED due to MGD in patients with moderate to severe symptoms.

Lumenis is Proud to Support Scars II, the Second International Scar Treatment Conference in Israel

Lumeni Ltd., the world’s largest energy-based medical device company for surgical, aesthetic, and ophthalmic applications, announced that it will again be supporting the International Scar Treatment Conference in Israel, which will be held for the second time in Tel Aviv, on March 21st-22nd, 2018.

Events

Events and conferences held by Lumenis about laser aesthetics and laser equipment

Homepage

Lumenis is a pioneer in the field of aesthetic medicine and was the first to introduce many technologies in the field, such as Intense Pulsed Light and CO2 laser skin resurfacing. At Lumenis Aesthetic we put performance and service as core values, so that our customers can deliver the best possible results for their patients.

VIDEO: Assign staff member to work with dry eye patients

Cases in Dr. Carly Rose’s dry eye clinic have “exploded” when adding OptiLight to her practice. Her secrets: Offer OptiLight early to get a head of inflammation and assign a staff member to be the dry eye “coach”.